NO994821L - Fremgangsmåte ved inaktivering av patogener, spesielt virus, i et biologisk materiale - Google Patents

Fremgangsmåte ved inaktivering av patogener, spesielt virus, i et biologisk materiale

Info

Publication number
NO994821L
NO994821L NO994821A NO994821A NO994821L NO 994821 L NO994821 L NO 994821L NO 994821 A NO994821 A NO 994821A NO 994821 A NO994821 A NO 994821A NO 994821 L NO994821 L NO 994821L
Authority
NO
Norway
Prior art keywords
biological material
inactivating pathogens
especially viruses
mmol
incubation
Prior art date
Application number
NO994821A
Other languages
English (en)
Other versions
NO994821D0 (no
Inventor
Hans-Peter Schwarz
Gerold Zerlauth
Peter Turecek
Original Assignee
Baxter Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Baxter Ag filed Critical Baxter Ag
Publication of NO994821D0 publication Critical patent/NO994821D0/no
Publication of NO994821L publication Critical patent/NO994821L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2/00—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor
    • A61L2/0005—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor for pharmaceuticals, biologicals or living parts
    • A61L2/0011—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor for pharmaceuticals, biologicals or living parts using physical methods
    • A61L2/0017—Filtration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2/00—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor
    • A61L2/0005—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor for pharmaceuticals, biologicals or living parts
    • A61L2/0011—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor for pharmaceuticals, biologicals or living parts using physical methods
    • A61L2/0023—Heat
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2/00—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor
    • A61L2/0005—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor for pharmaceuticals, biologicals or living parts
    • A61L2/0082—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor for pharmaceuticals, biologicals or living parts using chemical substances
    • A61L2/0088—Liquid substances
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2/00—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor
    • A61L2/16—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor using chemical substances
    • A61L2/18—Liquid substances or solutions comprising solids or dissolved gases
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)

Abstract

Det er beskrevet en fremgangsmåte for inaktivering av patogener, spesielt virus, i et biologisk mate-riale ved inkubering med et kjemisk middel, som er kjennetegnet ved at inkuberingen foretas i nærvær av et eluotropt salt tilsvarende en NaCl-konsen-trasjon på minst 200 mmol/1, fortrinnsvis minst 3 00 mmol/1, samt et kromatografisk renset preparat som inneholder protrombinkompleks.
NO994821A 1997-04-08 1999-10-04 Fremgangsmåte ved inaktivering av patogener, spesielt virus, i et biologisk materiale NO994821L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
AT0059497A AT405608B (de) 1997-04-08 1997-04-08 Verfahren zur inaktivierung von pathogenen, insbesondere von viren, in einem biologischen material
PCT/AT1998/000090 WO1998044941A1 (de) 1997-04-08 1998-04-06 Verfahren zur inaktivierung von pathogenen, insbesondere von viren, in einem biologischen material

Publications (2)

Publication Number Publication Date
NO994821D0 NO994821D0 (no) 1999-10-04
NO994821L true NO994821L (no) 1999-12-02

Family

ID=3494721

Family Applications (1)

Application Number Title Priority Date Filing Date
NO994821A NO994821L (no) 1997-04-08 1999-10-04 Fremgangsmåte ved inaktivering av patogener, spesielt virus, i et biologisk materiale

Country Status (14)

Country Link
EP (1) EP0973543B1 (no)
JP (1) JP2001519790A (no)
AT (1) AT405608B (no)
AU (1) AU739845B2 (no)
BR (1) BR9807938A (no)
CA (1) CA2285976A1 (no)
DE (1) DE59810716D1 (no)
DK (1) DK0973543T3 (no)
ES (1) ES2214701T3 (no)
HU (1) HUP0000825A3 (no)
NO (1) NO994821L (no)
PT (1) PT973543E (no)
SK (1) SK138999A3 (no)
WO (1) WO1998044941A1 (no)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10012732A1 (de) * 2000-03-18 2001-09-20 Aventis Behring Gmbh Thrombin-Zubereitungen und Verfahren zu ihrer Herstellung
WO2005033140A1 (ja) * 2003-09-30 2005-04-14 Juridical Foundation The Chemo-Sero-Therapeutic Research Institute 高純度血液凝固ｉｘ因子調製物およびその精製方法
EP1711513B1 (en) * 2003-12-01 2014-07-02 Novo Nordisk Health Care AG Nanofiltration of factor vii solutions to remove virus
US9493744B2 (en) 2012-06-20 2016-11-15 Genentech, Inc. Methods for viral inactivation and other adventitious agents

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AT368883B (de) * 1980-07-22 1982-11-25 Immuno Ag Verfahren zur herstellung einer neuen blutgerinnungsfoerdernden praeparation auf basis von humanproteinen
EP0124506B1 (de) * 1983-05-02 1988-08-17 IMMUNO Aktiengesellschaft für chemisch-medizinische Produkte Verfahren zur Inaktivierung von vermehrungsfähigen Krankheitserregern
US4540573A (en) * 1983-07-14 1985-09-10 New York Blood Center, Inc. Undenatured virus-free biologically active protein derivatives
US4673733A (en) * 1985-04-11 1987-06-16 Sudhish Chandra Treatment of biological and pharmaceutical products adsorbed on a solid phase with virus and pyrogen inactivating agents
DE3730533A1 (de) * 1987-09-11 1989-03-30 Biotest Pharma Gmbh Verfahren zur sterilisation von plasma oder plasmafraktionen
US5156973A (en) * 1988-11-23 1992-10-20 Edward Shanbrom Antiviral blood sampling process and apparatus
JP3145696B2 (ja) * 1990-10-05 2001-03-12 日本ケミカルリサーチ株式会社 分泌型免疫グロブリンａ製剤の製造法
AT398079B (de) * 1991-11-04 1994-09-26 Immuno Ag Präparation mit thrombinaktivität sowie verfahren zu ihrer herstellung
IL104530A0 (en) * 1992-01-27 1993-05-13 Cryopharm Corp Method of inactivation of viral and bacterial blood contaminants
DE19506633A1 (de) * 1995-02-25 1996-08-29 Octapharma Ag Verfahren zur Herstellung von Faktor IX aus biologischen Quellen
FI952196A0 (fi) * 1995-05-08 1995-05-08 Suomen Punainen Risti Veripalv Framstaellning av immunoglobulin
DE19531637A1 (de) * 1995-08-28 1997-03-06 Immuno Ag Pharmazeutische Zusammensetzung zur Behandlung von Blutgerinnungsstörugnen, Verfahren zur Herstellung derselben und deren Verwendung
US6686191B1 (en) * 1995-09-22 2004-02-03 Bayer Healthcare Llc Preparation of virally inactivated intravenously injectable immune serum globulin

Also Published As

Publication number Publication date
EP0973543A1 (de) 2000-01-26
EP0973543B1 (de) 2004-02-04
JP2001519790A (ja) 2001-10-23
NO994821D0 (no) 1999-10-04
SK138999A3 (en) 2000-06-12
AU6711898A (en) 1998-10-30
PT973543E (pt) 2004-06-30
HUP0000825A1 (en) 2000-07-28
AT405608B (de) 1999-10-25
HUP0000825A3 (en) 2001-12-28
DK0973543T3 (da) 2004-05-24
CA2285976A1 (en) 1998-10-15
AU739845B2 (en) 2001-10-18
ES2214701T3 (es) 2004-09-16
ATA59497A (de) 1999-02-15
BR9807938A (pt) 2000-02-22
WO1998044941A1 (de) 1998-10-15
DE59810716D1 (de) 2004-03-11

Similar Documents

Publication Publication Date Title
ES2101077T5 (es) Procedimiento para la inactivacion de priones.
ES2130232T3 (es) N,n'-diacilhidrazinas n' sustituidas como insecticidas.
ATE67092T1 (de) Verwendung von chlordioxidgas als chemisches sterilisierungsmittel.
EA200000759A1 (ru) Производные 2-(пурин-9-ил)-тетрагидрофуран-3,4-диола
NO308601B1 (no) Tricykliske benzazepiner og farmasøytisk preparat inneholdende disse
ES2087156T3 (es) Metodos para la inactivacion de virus en composiciones farmaceuticas contaminadas por virus.
DE60217867D1 (de) Neue picolinaminderivate und deren verwendung als fungizide
IL172868A0 (en) Process for preparing an alpha-1-antitrypsin solution
DK1129212T3 (da) Screeningsproces for antibakterielle midler
FI955690A (fi) Menetelmä biologisten seosten steriloimiseksi ja menetelmällä tuotettutuote
SE9301582D0 (sv) Purification of plasma proteins
DE69617005D1 (de) 2-amino-benzoxazinone zur behandlung von viralen infektionen
KR960021057A (ko) 아크리딘 또는 아크리딘 유도체 보조하의 바이러스의 불활성화 방법
NO994821L (no) Fremgangsmåte ved inaktivering av patogener, spesielt virus, i et biologisk materiale
DE69533043D1 (de) Acrylamid-derivate und verfahren zu deren herstellung
NO20006109L (no) Analytisk metode som benytter multippel virusmerking
DE60104687D1 (de) Mikrofiltration unter verwendung von aktivkohle
FR2651133B1 (fr) Procede de decontamination par des solutions de peracides de materiaux contamines par des agents toxiques.
DK0471259T3 (da) Phenylsulfonamid-substituerede pyridinalken- og -aminooxyalkancarboxylsyre-derivater
ES2099678B1 (es) Procedimiento para la inactivacion de virus en proteinas.
ATE209683T1 (de) Planze resistent gegen mindestens zwei viren und dessen preparation
DK1001942T3 (da) Polyhydroxybutylpyraziner, deres fremstilling samt medikamenter indeholdende disse forbindelser
BR9915572A (pt) Processo de tratamento de doença de célula falciforme e talassemia
DE69711422D1 (de) Verwendung von (r)-verapamil als medizin zur behandlung von angina
FR2643356B1 (fr) Procede de destruction des hypochlorites dans une solution de chlorate

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application